This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Sep;25(3):599.

doi: 10.1038/s41391-022-00539-0.

Correction: Germline alterations among Hispanic men with prostate cancer

Elizabeth Pan¹, Justin Shaya¹, Lisa Madlensky¹, J Michael Randall¹, Juan Javier-Desloges², Frederick E Millard¹, Brent Rose³, J Kellogg Parsons², Sarah M Nielsen⁴, Kathryn E Hatchell⁴, Edward D Esplin⁴, Robert L Nussbaum⁴, Nicole Weise¹, James Murphy¹, Maria Elena Martinez¹, Rana R McKay⁵

Affiliations

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.
² Department of Urology, University of California San Diego, La Jolla, CA, USA.
³ Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
⁴ Invitae Corporation, San Francisco, CA, USA.
⁵ Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu.

PMID: 35488122
DOI: 10.1038/s41391-022-00539-0

Published Erratum

Correction: Germline alterations among Hispanic men with prostate cancer

Elizabeth Pan et al. Prostate Cancer Prostatic Dis. 2022 Sep.

. 2022 Sep;25(3):599.

doi: 10.1038/s41391-022-00539-0.

Authors

Elizabeth Pan¹, Justin Shaya¹, Lisa Madlensky¹, J Michael Randall¹, Juan Javier-Desloges², Frederick E Millard¹, Brent Rose³, J Kellogg Parsons², Sarah M Nielsen⁴, Kathryn E Hatchell⁴, Edward D Esplin⁴, Robert L Nussbaum⁴, Nicole Weise¹, James Murphy¹, Maria Elena Martinez¹, Rana R McKay⁵

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.
² Department of Urology, University of California San Diego, La Jolla, CA, USA.
³ Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
⁴ Invitae Corporation, San Francisco, CA, USA.
⁵ Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu.

PMID: 35488122
DOI: 10.1038/s41391-022-00539-0

No abstract available

PubMed Disclaimer

Erratum for

Germline alterations among Hispanic men with prostate cancer.
Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. Pan E, et al. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):561-567. doi: 10.1038/s41391-022-00517-6. Epub 2022 Feb 28. Prostate Cancer Prostatic Dis. 2022. PMID: 35228665

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group